Loading icon
Press enter or spacebar to select a desired language.
Research
Press enter or spacebar to select a desired language.

PubMed COVID-19 Clinical Care

541 - 550 of 51504 results found

Microfluidics produced ATRA-loaded PLGA NPs reduced tuberculosis burden in alveolar epithelial cells and enabled high delivered dose under simulated human breathing pattern in 3D printed head models

Date
Wednesday, February 28, 2024 - 4:00 AM
Description
Tuberculosis, caused by Mycobacterium tuberculosis (Mtb), is second only to COVID-19 as the top infectious disease killer worldwide. Multi-drug resistant TB (MDR-TB) may arise because of poor patient adherence to medications due to lengthy treatment

PulmoNet: a novel deep learning based pulmonary diseases detection model

Date
Wednesday, February 28, 2024 - 4:00 AM
Description
Pulmonary diseases are various pathological conditions that affect respiratory tissues and organs, making the exchange of gas challenging for animals inhaling and exhaling. It varies from gentle and self-limiting such as the common cold and catarrh

Examining Barriers to Early Hearing Diagnosis

Date
Wednesday, February 28, 2024 - 4:00 AM
Description
CONCLUSIONS: Although some known barriers for EHDI can be universal, other factors may have a differential impact on an infant's timeline to diagnosis based on their specific location, which can interact differently with additional known barriers

Plitidepsin as an Immunomodulator against Respiratory Viral Infections

Date
Wednesday, February 28, 2024 - 4:00 AM
Description
Plitidepsin is a host-targeted compound known for inducing a strong anti-SARS-CoV-2 activity, as well as for having the capacity of reducing lung inflammation. Because IL-6 is one of the main cytokines involved in acute respiratory distress syndrome